Mark Blemler

Q: What is Mark Blemler email address?

Email Mark Blemler at mark.blemler@onco360.com. This email is the most updated Mark Blemler email found in 2026.

Q: How to contact Mark Blemler?

To contact Mark Blemler send an email to mark.blemler@onco360.com. (updated on October 29, 2024)

Regional Director at Onco360 Oncology Pharmacy | Leland, North Carolina, United States

About Mark Blemler

Mark Blemler serves as the Regional Director at Onco360 Oncology Pharmacy, where he leverages over 30 years of comprehensive experience across various sectors of the pharmaceutical industry. His multifaceted background spans retail, mail order, pharmacy benefit management (PBM), sterile compounding, patient assistance programs (PAP), hospital settings, and specialty pharmacy, providing him with a unique perspective on the intricacies of oncology pharmacy operations. In his current role, Mark is instrumental in prescriber maintenance, patient compliance, and increasing referrals, ensuring that Onco360 remains at the forefront of patient-centered care in oncology.

Mark's expertise in building strong relationships is pivotal to his success. He understands that fostering trust with healthcare providers and patients alike is essential for enhancing treatment adherence and improving patient outcomes. His experience in clinical operations and sales equips him with the skills necessary to navigate the complexities of oncology, allowing him to effectively communicate the value of Onco360’s services to prescribers and patients.

In addition to his relationship-building skills, Mark is adept at quality control and operational efficiency, ensuring that pharmacy technicians and staff adhere to the highest standards of care. His proficiency in organic chemistry and familiarity with tools like Microsoft Word and Excel further enhance his ability to analyze data and streamline processes. Mark Blemler’s leadership and communication skills not only inspire his team but also drive the continuous improvement of patient care strategies, making him a vital asset to Onco360 and the broader oncology community.

Mark Blemler Work